Business Description
Inotiv Inc
NAICS : 325412
SIC : 2834
ISIN : US45783Q1004
Total Employee Number:
2,046Description
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.11 | |||||
Debt-to-Equity | 6.33 | |||||
Debt-to-EBITDA | 70.8 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -1.56 | |||||
Beneish M-Score | -3.11 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -11.1 | |||||
3-Year EPS without NRI Growth Rate | 5.7 | |||||
3-Year FCF Growth Rate | 21.2 | |||||
3-Year Book Growth Rate | -34.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.61 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 22.64 | |||||
9-Day RSI | 23.45 | |||||
14-Day RSI | 26.94 | |||||
3-1 Month Momentum % | -2.34 | |||||
6-1 Month Momentum % | -56.24 | |||||
12-1 Month Momentum % | -85.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.27 | |||||
Quick Ratio | 0.21 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 38.04 | |||||
Days Sales Outstanding | 47.54 | |||||
Days Payable | 38.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.3 | |||||
Shareholder Yield % | -5786.59 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 22.94 | |||||
Operating Margin % | -8.97 | |||||
Net Margin % | -17.14 | |||||
EBITDA Margin % | 1.36 | |||||
FCF Margin % | -2.68 | |||||
OCF Margin % | 0.07 | |||||
ROE % | -69.73 | |||||
ROA % | -11.65 | |||||
ROIC % | -4.12 | |||||
3-Year ROIIC % | -31.86 | |||||
ROC (Joel Greenblatt) % | -19.57 | |||||
ROCE % | -13.25 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.01 | |||||
Price-to-Operating-Cash-Flow | 1.2 | |||||
EV-to-EBIT | -9.67 | |||||
EV-to-EBITDA | 68.66 | |||||
EV-to-Revenue | 0.93 | |||||
EV-to-FCF | -34.75 | |||||
Price-to-GF-Value | 0.01 | |||||
Earnings Yield (Greenblatt) % | -10.34 | |||||
FCF Yield % | -3248.69 | |||||
Forward Rate of Return (Yacktman) % | 200.4 |
Inotiv Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inotiv Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2026-12-04 | In 159 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-12-03 16:30 | In 159 days | ||
| Fourth quarter earnings results for 2026 | 2026-12-03 | In 158 days | ||
| Third quarter earnings conference call for 2026 | 2026-08-06 16:30 | In 40 days | ||
| Third quarter earnings results for 2026 | 2026-08-06 | In 39 days | ||
| General meeting for 2026 | 2026-07-03 | In 5 days | ||
| Second quarter earnings results for 2026 | 2026-05-11 | 0.30 (-1.43%) | ||
| First quarter earnings conference call for 2026 | 2026-02-09 08:30 | 0.42 (+0.80%) | ||
| First quarter earnings results for 2026 | 2026-02-09 | 0.42 (+0.80%) | ||
| Annual report for 2025 | 2025-12-05 | 0.88 (+1.28%) |
Show
Entries
Guru Commentaries on OTCPK:NOTVQ
No articles.
Press Release
Articles on Inotiv Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers